Print Page  |  Close Window

News Release

PRA Health Sciences Partners with IMPACT2030

RALEIGH, N.C., Feb. 12, 2018 (GLOBE NEWSWIRE) -- PRA Health Sciences, Inc. (NASDAQ:PRAH) is pleased to announce that it has joined IMPACT2030 as a collaborating partner. IMPACT2030 is a coalition of businesses working in partnership to help achieve the United Nations’ Sustainable Development Goals (SDGs). Launched in 2015 and signed by 193 world leaders, the goals look to end hunger, poverty, improve quality education and address climate action across the globe.

“PRA is committed to aligning our corporate sustainability objectives with the international community,” said David Dockhorn, Executive Vice President, and Corporate Compliance Officer.  “By focusing our efforts on the SDGs that are most relevant to PRA’s core business, we will maximize the impact of our work and our employee engagement and charity related activities that fall within our PRA Cares initiative. We are proud to join public and private institutions around the world in a common mission to address today’s most pressing environmental and societal challenges.”

IMPACT2030 directly addresses the SDGs at the local, national and regional level by facilitating private sector participation through corporate employee volunteer programs and providing multiple opportunities for engagement and participation.

“IMPACT2030 is proud to welcome PRA Health Sciences to our global network of companies and stakeholders, each committed to aligning their employee volunteer programs with the UN’s SDGs,” added Sue Stephenson, IMPACT2030 Interim CEO. “Together we will be able to create a blueprint to inspire local action and demonstrate the extraordinary passion of PRA employees around the world to increase their societal impact on their communities.”


IMPACT2030 is the only private sector, partnership-led initiative focused on leveraging employee volunteer programs to directly and substantially contribute to the achievement of the United Nation’s global Sustainable Development Goals (SDG). The initiative takes a collective and multi-sector approach to impact the SDGs and leverages economies of scale by encouraging collective and cooperative volunteering efforts of member organizations globally.

Learn more about IMPACT2030 and join the global movement to leverage human capital to achieve the Sustainable Development Goals at


PRA is one of the world's leading global contract research organizations, by revenue, providing outsourced clinical development services to the biotechnology and pharmaceutical industries. PRA’s global clinical development platform includes More than 70 offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East, and over 15,000 employees worldwide. Since 2000, PRA has participated in approximately 3,500 clinical trials worldwide. In addition, PRA has participated in the pivotal or supportive trials that led to U.S. Food and Drug Administration or international regulatory approval of more than 70 drugs. To learn more about PRA, please visit

Media Inquiries: Christine Rogers, Director, Public Relations, Corporate Communications

Primary Logo

PRA Health Sciences, Inc.